BNP Paribas Financial Markets
HURA

BNP Paribas Financial Markets’s TuHURA Biosciences HURA Stock Holding History

BNP Paribas Financial Markets’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Sell
4,669
-4,841
-51% -$11.3K ﹤0.01% 5369
2026
Q1 		$17K Buy
9,510
+1,900
+25% +$2.33K ﹤0.01% 5121
2025
Q4 		$5.76K Buy
7,610
+2,018
+36% +$3.86K ﹤0.01% 5241
2025
Q3 		$13.9K Buy
5,592
+1,780
+47% +$4.68K ﹤0.01% 4965
2025
Q2 		$8.5K Buy
+3,812
New +$12.9K ﹤0.01% 4877

Other funds holding HURA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BNP Paribas Financial Markets's HURA Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its TuHURA Biosciences (HURA) stake by 51% in Q2 2026, selling an estimated $11.3K and leaving 4,669 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5369.

BNP Paribas Financial Markets first reported a position in HURA in Q2 2025 and has held it in 5 quarters since. The position peaked at $17K in Q1 2026. 72 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • BNP Paribas Financial Markets held 4,669 shares of TuHURA Biosciences worth $10.9K as of Q2 2026.
  • BNP Paribas Financial Markets sold 4,841 TuHURA Biosciences shares in Q2 2026, an estimated $11.3K.
  • TuHURA Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5369 holding.
  • BNP Paribas Financial Markets first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Financial Markets's TuHURA Biosciences position peaked at $17K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.